Senior Vice President, Outcome Capital
Oded Ben-Joseph, PhD, MBA
Managing Director, Outcome Capital
As a highly specialized life science advisory and investment banking firm, Outcome Capital looks to identify emerging trends that effect how researchers and clinicians understand, diagnose, and treat disease. One emerging trend we have noted is the integration of advancements in biological sciences, such as tools and techniques, and digital technolo- gies, such as machine learning (ML) and artificial intelligence (AI). This merger has given rise to a new field – spatial biology.
BOSTON, MA & RESTON, Va.–(BUSINESS WIRE)–Outcome Capital (www.outcomecapital.com) today announced that Steven Wardell and Karl Hess have joined the firm as Senior Advisors for its rapidly growing life science and healthcare practice, bolstering the firm’s expertise in the digital health segment. As business leaders with extensive hands-on operating and entrepreneurial expertise, Messrs. Hess and Wardell […]Read More
RESTON, Va.–(BUSINESS WIRE)–Outcome Capital, an advisory and investment banking firm that serves middle market growth companies in IT services, software, managed services, ADGS, healthcare and life sciences, is pleased to announce that Evergreen Systems, Inc. (the “Company”) has been acquired by Sunstone Partners, a California-based private equity firm. Outcome Capital provided exclusive advisory services to […]Read More